EPO and diabetic retinopathy: During diabetic retinopathy, inner blood-retinal barrier (BRB) breakdown occurs while EPO prevents this damage via the inhibition of microglial activation and phagocytosis mediated by the SRC/AKT/COFFILIN signaling pathway [108].